Literature DB >> 20202300

Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis.

A Nodieva1, I Jansone, L Broka, I Pole, G Skenders, V Baumanis.   

Abstract

SETTING: Multidrug-resistant tuberculosis (MDR-TB) is a serious health problem in Eastern European countries, including Latvia.
OBJECTIVE: To investigate the proportion of tuberculosis, including MDR-TB cases, attributable to recent transmission and risk factors associated with clustering.
DESIGN: Retrospective nested case-control study. The data set incorporated a wide spectrum of social features, as well as genotypes of Mycobacterium tuberculosis isolates determined by insertion sequence 6110 restriction fragment length polymorphism analysis of PvuII cleaved genomic DNA and spoligotyping.
RESULTS: In comparison with non-clustered M. tuberculosis, the Beijing genotype (OR 12.15) and multidrug resistance (OR 5.61, P < 0.01) were associated with clustering. In comparison with clustered drug-susceptible M. tuberculosis, clustering of MDR M. tuberculosis was associated with Beijing genotype (OR 41.67), previous hospitalisation (OR 18.33) and previous TB treatment (OR 17.68, P < 0.05). Direct epidemiological links in hospitals were found for almost one third (32%) of MDR Beijing cases.
CONCLUSIONS: MDR cases were more likely to be found in clusters than drug-susceptible cases (74.0% vs. 33.6%). Recent nosocomial transmission of MDR-TB is an important risk factor for the spread of multiresistance, and is associated with the Beijing genotype. Special attention should be paid to infection control measures in hospitals and ambulatory treatment should be enforced.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202300

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  17 in total

1.  Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Authors:  Olga Ignatyeva; Irina Kontsevaya; Alexander Kovalyov; Yanina Balabanova; Vladislav Nikolayevskyy; Kadri Toit; Anda Dragan; Daniela Maxim; Svetlana Mironova; Tiina Kummik; Ionela Muntean; Ekaterina Koshkarova; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

Review 2.  Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

Authors:  Keertan Dheda; Tawanda Gumbo; Neel R Gandhi; Megan Murray; Grant Theron; Zarir Udwadia; G B Migliori; Robin Warren
Journal:  Lancet Respir Med       Date:  2014-03-24       Impact factor: 30.700

3.  Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis.

Authors:  Ashwin S Dharmadhikari; Randall J Basaraba; Martie L Van Der Walt; Karin Weyer; Matsie Mphahlele; Kobus Venter; Paul A Jensen; Melvin W First; Sydney Parsons; David N McMurray; Ian M Orme; Edward A Nardell
Journal:  Tuberculosis (Edinb)       Date:  2011-04-07       Impact factor: 3.131

4.  Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward.

Authors:  Ashwin S Dharmadhikari; Matsie Mphahlele; Anton Stoltz; Kobus Venter; Rirhandzu Mathebula; Thabiso Masotla; Willem Lubbe; Marcello Pagano; Melvin First; Paul A Jensen; Martie van der Walt; Edward A Nardell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-09       Impact factor: 21.405

5.  High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova.

Authors:  Helen E Jenkins; Valeriu Crudu; Viorel Soltan; Ana Ciobanu; Liliana Domente; Ted Cohen
Journal:  Eur Respir J       Date:  2014-02-20       Impact factor: 16.671

6.  Diagnostic accuracy of the genotype MTBDRsl assay for rapid diagnosis of extensively drug-resistant tuberculosis in HIV-coinfected patients.

Authors:  Irina Kontsevaya; Olga Ignatyeva; Vladyslav Nikolayevskyy; Yanina Balabanova; Alexander Kovalyov; Andrey Kritsky; Olesya Matskevich; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-11-14       Impact factor: 5.948

7.  Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Authors:  H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

8.  Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.

Authors:  Helen E Jenkins; Valeriu Plesca; Anisoara Ciobanu; Valeriu Crudu; Irina Galusca; Viorel Soltan; Aliona Serbulenco; Matteo Zignol; Andrei Dadu; Masoud Dara; Ted Cohen
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

Review 9.  Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward.

Authors:  C D Acosta; A Dadu; A Ramsay; M Dara
Journal:  Public Health Action       Date:  2014-10-21

10.  Genome sequencing of ovine isolates of Mycobacterium avium subspecies paratuberculosis offers insights into host association.

Authors:  John P Bannantine; Chia-wei Wu; Chungyi Hsu; Shiguo Zhou; David C Schwartz; Darrell O Bayles; Michael L Paustian; David P Alt; Srinand Sreevatsan; Vivek Kapur; Adel M Talaat
Journal:  BMC Genomics       Date:  2012-03-12       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.